No abstract available.
Angiogenesis Inducing Agents*

No abstract available.
Angiogenesis Inducing Agents* ; Intracranial Aneurysm*

No abstract availalbe.
Angiogenesis Inducing Agents* ; Vascular Endothelial Growth Factor A

Background: Current medical management of endometriosis leads to suppression of ovulation and will not be helpful for women with endometriosis who are desirous of pregnancy. Thus, drugs that can both treat endometriosis and its associated infertility are highly warranted. Objective: Anti-angiogenic agents are potential drugs for patients with endometriosis and infertility. Among these drugs, dopamine agonist (DA) is promising since it does not interfere with ovulation, is safe, and not teratogenic. The aim of the study is to determine the efficacy and safety of DA for improving reproductive outcomes in women with endometriosis and infertility. Methods: A qualitative narrative review was done from inception to July 31, 2022 using the appropriate MeSH terms in PubMed, Cochrane Database of Systematic Reviews, the Cochrane Central Register of Controlled Trials, ClinicalTrial.gov, and World Health Organization International Clinical Trials Registry Platform. Date analysis was through qualitative analysis and synthesis of researches and their outcome measures. Results: No studies used the core outcomes for trials evaluating treatments for infertility associated with endometriosis. All the included articles in the review supported the possible anti-angiogenic effects of DA on the vascular endothelial growth factor [VEGF] /VEGF receptor system. The use of DA does not have an effect on ovulation and menstrual cyclicity. Studies on safety profile of DA were consistent with existing data. Conclusion Most of studies reviewed demonstrated that DA were effective in reducing endometriotic lesions. However, further research is required to establish whether this anti-angiogenic effect can improve reproductive outcomes in women with endometriosis-associated infertility.
Endometriosis ; Dopamine Agonists ; Infertility ; Angiogenesis Inducing Agents ; Angiogenesis Inhibitors

No abstract available.
Airway Remodeling ; Angiogenesis Inducing Agents ; Rhinitis ; Rhinitis, Allergic, Perennial

PURPOSE: VEGF is thought to be an important angiogenic factor playing significant a role in the aggressiveness of malignant tumor by stimulating neovascularization. We morphologically investicated the tumor angiogenesis in terms of the presence of VEGF expression in advanced gastric carcinoma. MATERIALS AND METHODS: We performed immunohistochemical stains for VEGF, CD 34, and MIB-1 (Ki-67) on the 51 paraffin-embedded tissue sections. The degree of angiogenesis was determined by counting microvessel densities and their Ki-67 labelling indices of endothelial cells within the tumors. We evaluated the correlation between the expression of VEGF, angiogenesis and clinicopathologic factors such as histologic differentiation, depth of invasion, and lymph node metastasis. RESULTS: Immunoreactivity for VEGF revealed positivity in 34 out of 51 cases (66.7%). Microvessel densities and Ki-67 labelling indices of endothelial cells reflecting angiogenesis were higher in VEGF-positive tumors than VEGF-negative tumors. There were no conelations between VEGF expression, histologic differentiation and the depth of invasion. We failed to evaluate the conelation of VEGF expression and lymph node metastasis. CONCLUSION: This study suggests that VEGF expressian is closely related to tumor asso- ciated angiogenesis in advanced gastric carcinoma. Considering that tumor growth depends on angiogenesis, therapies reducing VEGF may be a means of inhibiting angiogenesis and tumor aggressiveness.
Angiogenesis Inducing Agents ; Coloring Agents ; Endothelial Cells ; Lymph Nodes ; Microvessels ; Neoplasm Metastasis ; Vascular Endothelial Growth Factor A*

Sex hormone estrogen is one of the most active intrinsic angiogenesis regulators; its therapeutic use has been limited due to its carcinogenic potential. Plant-derived phytoestrogens are attractive alternatives, but reports on their angiogenic activities often lack in-depth analysis and sometimes are controversial. Herein, we report a data-mining study with the existing literature, using IPA system to classify and characterize phytoestrogens based on their angiogenic properties and pharmacological consequences. We found that pro-angiogenic phytoestrogens functioned predominantly as cardiovascular protectors whereas anti-angiogenic phytoestrogens played a role in cancer prevention and therapy. This bidirectional regulation were shown to be target-selective and, for the most part, estrogen-receptor-dependent. The transactivation properties of ERα and ERβ by phytoestrogens were examined in the context of angiogenesis-related gene transcription. ERα and ERβ were shown to signal in opposite ways when complexed with the phytoestrogen for bidirectional regulation of angiogenesis. With ERα, phytoestrogen activated or inhibited transcription of some angiogenesis-related genes, resulting in the promotion of angiogenesis, whereas, with ERβ, phytoestrogen regulated transcription of angiogenesis-related genes, resulting in inhibition of angiogenesis. Therefore, the selectivity of phytoestrogen to ERα and ERβ may be critical in the balance of pro- or anti-angiogenesis process.
Angiogenesis Inducing Agents ; metabolism ; Angiogenesis Inhibitors ; metabolism ; Animals ; Gene Expression Regulation ; Humans ; Phytoestrogens ; metabolism ; Receptors, Estrogen ; genetics ; metabolism ; Signal Transduction

PURPOSE: HIF-1alpha (Hypoxia inducible factor-1alpha) and VEGF (vascular endothelial growth factor) have been reported to be involved in tumor growth and metastasis, but only a little data on the roles of HIF-1alpha and VEGF in renal cell carcinomas are available, and few studies have yet evaluated their prognostic values. The aim of the present study was to assess the HIF-1alpha and VEGF expression and evaluate the relationships between HIF-1alpha/VEGF and the histopathological characteristics in renal cell carcinomas. MATERIALS AND METHODS: HIF-1alpha and VEGF immunohistochemical stainings were performed on formalin-fixed, paraffin-embedded archival tissues from 22 renal cell carcinoma tissues and 13 normal kidney tissues, used as a control group. The interpretation of the immunohistochemical stainings were semi-quantitatively performed by one pathologist. RESULTS: The expressions of HIF-1alpha and VEGF were significantly higher in the patient than the control group. The HIF-1alpha and VEGF expressions were correlated to each other, and inclined to be positively correlated with the pathological stage and grade of the renal cell carcinoma. CONCLUSIONS: The HIF-1alpha and VEGF expressions might be independent predictors of the outcome, as well as the stage and grade of renal cell carcinomas. This study suggests that HIF-1alpha and VEGF may be potential prognostic factors in renal cell carcinomas.
Angiogenesis Inducing Agents ; Anoxia* ; Carcinoma, Renal Cell* ; Humans* ; Kidney ; Neoplasm Metastasis ; Vascular Endothelial Growth Factor A*

Since Folkman's novel hypothesis, it is well known that tumors depend on the angiogenesis for their growth, expansion, and possibly metastasis. Several angiogenic factors have been identified and shown to be produced by tumors. In some cancers, the angoigenic activity in the tumor is correlated with the clinical outcome. Clinically, the presence of macroscopic or colposcopic abnormal vascular patterns of the uterine cervical lesions would suggest that the angiogenic activities are associated with various cervical squamous epithelial lesions. This study was designed to look at the relationship between angiogenesis and squamous epithelial lesions of the uterine cervix and to determine whether squamous intraepithelial lesions are angiogenic as cervical cancers are. Tissue sections from 53 surgical specimens(6 normal cervix, 4 chronic cervictis, 9 low grade SII, 8 high grade SIL, 7 MIC, 19 squamous cell carcinoma) were immunohistochemically stained for CD 34 a specific marker for endothelial cels. Stained vessels in the most intense area on a X200 light microscopic field were selected and counted automatically using computer software for color-image analysis. Stained vessel counts were 19.7 +/- 9.1 in normal cervix, 33.5 +/-5.8 in chronic cervicitis, 38.8 +/- 10.9 in LGSIL, 67.0 +/- 23.6 in HGSIL, and 73.4 +/- 20.6 in microinvasive carcinoma, 77.8 +/- 28.7 in squamous cell carcinoma, respectively. Vessel counts showed a statistically increasing tendency in more advanced squamous epithelial lesins. Tumor angiogenesis is not related to inflammatory response. Also, the process of the angiogenic switching may begin from low grade SIL to high grade SIL. This study suggests that the angiogenic activity also involved in SILs as invasive cancer are and may be related to grade of SELs.
Angiogenesis Inducing Agents ; Carcinoma, Squamous Cell ; Cervix Uteri* ; Female ; Neoplasm Metastasis ; Uterine Cervicitis

There exists a need to develop strategies that promote neovascularization in virtually all tissue engineering and regenerative medicine efforts. While research typically focuses on understanding and exploiting the role of angiogenic factors and vascular cells on new blood vessel formation, the activity of the immune system is being recognized to impact vascular formation and adaptation. This review will provide both an overview of the relationship of angiogenesis and the immune system, and how biomaterials may be designed to promote favorable angiogenesis by interaction between these 2 systems to promote effective vascularization.
Angiogenesis Inducing Agents ; Biocompatible Materials ; Blood Vessels ; Immune System ; Inflammation* ; Regenerative Medicine ; Tissue Engineering